Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel in Thyroid and Parathyroid Surgery
NCT04085913Phase 1Enrolling by invitation
- Sponsor
- University of Missouri
- Start
- Sep 2019
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of bupivacaine in postoperative pain (3 arms), sponsored by University of Missouri. Primary endpoint: Incidence of opioid use at 2 weeks. Started Sep 2019; status: enrolling by invitation.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04085913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04085913.